[Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction].
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D003374:Coumarins / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006406:Hematoma / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007192:Indenes / Q000009:adverse effects / Q000627:therapeutic use; D007659:Ketones / Q000009:adverse effects / Q000627:therapeutic use; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000534:rehabilitation; D010630:Phenindione / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D001593:Benzyl Compounds; D003374:Coumarins; D007192:Indenes; D007659:Ketones; D010630:Phenindione
Der Einfluss der Antikoagulantien-Dauertherapie auf Reinfarkt, Letalität und Rehabilitation Herzinfarktkranker. 4-Jahres-Beobachtung einer Infarkt-Dispensairebetreuung.